Octopus Biosafety (STU:OCR) Cyclically Adjusted Revenue per Share: €0.03 (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:OCR Octopus Biosafety STU:OCR
6 GF Score
Price €0.10
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety Cyclically Adjusted Revenue per Share?

Octopus Biosafety STU:OCR 6 Cyclically Adjusted Revenue per Share is €0.03 as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 6/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Octopus Biosafety's adjusted revenue per share data for the fiscal year that ended in Dec. 2024 was €0.004. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.03 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-22), Octopus Biosafety's current stock price is € 0.10. Octopus Biosafety's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec. 2024 was €0.03. Octopus Biosafety's Cyclically Adjusted PS Ratio of today is 3.33.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Octopus Biosafety was 12.50. The lowest was 2.50. And the median was 4.68.


Octopus Biosafety  (STU:OCR) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Octopus Biosafety's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.10/0.03
=3.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Octopus Biosafety was 12.50. The lowest was 2.50. And the median was 4.68.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Octopus Biosafety Cyclically Adjusted Revenue per Share Related Terms


Octopus Biosafety Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety Cyclically Adjusted Revenue per Share Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.03

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.03

STU:OCR vs SNDK, DELL, STX: Cyclically Adjusted Revenue per Share Comparison

For the Computer Hardware subindustry, Octopus Biosafety's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Octopus Biosafety Cyclically Adjusted PS Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Octopus Biosafety's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Octopus Biosafety's Cyclically Adjusted PS Ratio falls into.


STU:OCR
6GF Score
Octopus Biosafety STU:OCR
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Octopus Biosafety's adjusted Revenue per Share data for the fiscal year that ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.004/119.9500*119.9500
=0.004

Current CPI (Dec. 2024) = 119.9500.

Octopus Biosafety Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.100 100.180 0.120
201506 0.031 100.440 0.037
201606 0.000 100.630 0.000
201812 0.000 103.470 0.000
201912 0.000 104.980 0.000
202012 0.055 104.960 0.063
202112 0.017 107.850 0.019
202212 0.005 114.160 0.005
202312 0.015 118.390 0.015
202412 0.004 119.950 0.004

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.03 mean?
Octopus Biosafety (STU:OCR) has a Cyclically Adjusted Revenue per Share of €0.03 as of Dec. 2024. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Octopus Biosafety and its competitors.
Is Octopus Biosafety's Cyclically Adjusted Revenue per Share too high?
Octopus Biosafety's current Cyclically Adjusted Revenue per Share is €0.03. Overall, Octopus Biosafety has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Cyclically Adjusted Revenue per Share compare to SNDK and DELL?
Octopus Biosafety's Cyclically Adjusted Revenue per Share of €0.03 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Hardware company?
A good Cyclically Adjusted Revenue per Share depends on the Hardware industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Octopus Biosafety and its competitors. Octopus Biosafety's current Cyclically Adjusted Revenue per Share is €0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Cyclically Adjusted Revenue per Share of €0.03. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.03. Octopus Biosafety's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Cyclically Adjusted Revenue per Share is €0.03 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.

Key valuation signals for STU:OCR:

  • Cyclically Adjusted Revenue per Share: €0.03
  • GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
  • GF Score™: 6/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
6GF Score

Get the complete analysis for STU:OCR

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.05
GF Value